ATRA Financials
Atara Biotherapeutics Inc - Financial statements & key metrics
Stock Price
$4.32
Market Cap
$32.73M
P/E Ratio
1.6
EPS
$2.86
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$128.94M
Gross Profit
$107.93M
Operating Income
$-83.44M
Net Income
$-85.40M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$109.10M
Total Liabilities
$206.38M
Shareholders Equity
$-97.28M
Cash & Equivalents
$25.03M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-68.72M
CapEx
$246000
Free Cash Flow
$-68.96M
Profitability Metrics
Gross Margin
46.8%
Operating Margin
-1.0%
Net Margin
0.2%
ROE
-20.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ATRA revenue?
ATRA's most recent quarterly revenue was $128.94M. Annual revenue can be calculated by summing the four most recent quarters.
Is ATRA profitable?
ATRA reported a loss of $85.40M in the most recent quarter. The net profit margin is 0.2%.
What is ATRA market cap?
ATRA has a market capitalization of $32.73M, making it a small-cap stock.
Does ATRA have debt?
View ATRA's balance sheet for debt information.
What is ATRA cash flow?
ATRA's most recent quarterly free cash flow was $-68.96M.